New Therapies in Development for Myelofibrosis

Helen T. Chifotides; Srdan Verstovsek

doi:10.1016/S2152-2650(20)30467-5

New Therapies in Development for Myelofibrosis

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S69-S71
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	20
DOIs	https://doi.org/10.1016/S2152-2650(20)30467-5
State	Published - Sep 2020
Externally published	Yes

Keywords

CPI-0610
JAK inhibitor
Myeloproliferative Neoplasms (MPN)
imetelstat
navitoclax

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/S2152-2650(20)30467-5

Cite this

@article{8727f115f2864d6e8489a3d5388836f6,

title = "New Therapies in Development for Myelofibrosis",

keywords = "CPI-0610, JAK inhibitor, Myeloproliferative Neoplasms (MPN), imetelstat, navitoclax",

author = "Chifotides, {Helen T.} and Srdan Verstovsek",

year = "2020",

month = sep,

doi = "10.1016/S2152-2650(20)30467-5",

language = "English (US)",

volume = "20",

pages = "S69--S71",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Cancer Media Group",

}

TY - JOUR

T1 - New Therapies in Development for Myelofibrosis

AU - Chifotides, Helen T.

AU - Verstovsek, Srdan

PY - 2020/9

Y1 - 2020/9

KW - CPI-0610

KW - JAK inhibitor

KW - Myeloproliferative Neoplasms (MPN)

KW - imetelstat

KW - navitoclax

UR - http://www.scopus.com/inward/record.url?scp=85089815563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089815563&partnerID=8YFLogxK

U2 - 10.1016/S2152-2650(20)30467-5

DO - 10.1016/S2152-2650(20)30467-5

M3 - Article

C2 - 32862875

AN - SCOPUS:85089815563

SN - 2152-2650

VL - 20

SP - S69-S71

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

ER -

New Therapies in Development for Myelofibrosis

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this